FDA Approves 'Female Viagra'

The U.S. Food and Drug Administration has approved a libido-enhancing drug for women that has been dubbed "Female Viagra." The approval of the drug (flibanserin), which the FDA twice rejected before and now will be marketed as Addyi, comes with a series of explanations reflecting the agency’s concerns about serious side effects. These include a boxed warning that highlights the risks of low blood pressure and fainting in patients who drink alcohol while taking the drug, and a...

© La Voix de l'Amérique - mardi 18 août 2015